146 related articles for article (PubMed ID: 20420835)
1. Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells.
Cornez I; Taskén K
FEBS Lett; 2010 Jun; 584(12):2681-8. PubMed ID: 20420835
[TBL] [Abstract][Full Text] [Related]
2. The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP.
Stokka AJ; Mosenden R; Ruppelt A; Lygren B; Taskén K
Biochem J; 2009 Dec; 425(2):381-8. PubMed ID: 19857202
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells.
Mosenden R; Taskén K
Cell Signal; 2011 Jun; 23(6):1009-16. PubMed ID: 21130867
[TBL] [Abstract][Full Text] [Related]
4. A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration.
Posevitz-Fejfár A; Smída M; Kliche S; Hartig R; Schraven B; Lindquist JA
Eur J Immunol; 2008 Jan; 38(1):250-9. PubMed ID: 18085663
[TBL] [Abstract][Full Text] [Related]
5. The molecular machinery for cAMP-dependent immunomodulation in T-cells.
Taskén K; Stokka AJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):476-9. PubMed ID: 16856837
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.
Ruppelt A; Mosenden R; Grönholm M; Aandahl EM; Tobin D; Carlson CR; Abrahamsen H; Herberg FW; Carpén O; Taskén K
J Immunol; 2007 Oct; 179(8):5159-68. PubMed ID: 17911601
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.
Tasken K; Ruppelt A
Front Biosci; 2006 Sep; 11():2929-39. PubMed ID: 16720365
[TBL] [Abstract][Full Text] [Related]
8. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
9. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
[TBL] [Abstract][Full Text] [Related]
10. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia.
Fouassier L; Duan CY; Feranchak AP; Yun CH; Sutherland E; Simon F; Fitz JG; Doctor RB
Hepatology; 2001 Jan; 33(1):166-76. PubMed ID: 11124833
[TBL] [Abstract][Full Text] [Related]
11. Molecular architecture of signal complexes regulating immune cell function.
Torgersen KM; Aandahl EM; Taskén K
Handb Exp Pharmacol; 2008; (186):327-63. PubMed ID: 18491059
[TBL] [Abstract][Full Text] [Related]
12. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
13. PAG-associated FynT regulates calcium signaling and promotes anergy in T lymphocytes.
Davidson D; Schraven B; Veillette A
Mol Cell Biol; 2007 Mar; 27(5):1960-73. PubMed ID: 17210649
[TBL] [Abstract][Full Text] [Related]
14. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.
Jiménez-Periañez A; Ojeda G; Criado G; Sánchez A; Pini E; Madrenas J; Rojo JM; Portolés P
J Leukoc Biol; 2005 Dec; 78(6):1386-96. PubMed ID: 16301324
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanism of immunological synapse formation].
Saito T; Sakakibara M
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2227-33. PubMed ID: 12518441
[No Abstract] [Full Text] [Related]
16. Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.
Brudvik KW; Taskén K
Br J Pharmacol; 2012 May; 166(2):411-9. PubMed ID: 22141738
[TBL] [Abstract][Full Text] [Related]
17. LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways.
Wange RL
Sci STKE; 2000 Dec; 2000(63):re1. PubMed ID: 11752630
[TBL] [Abstract][Full Text] [Related]
18. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton.
Brdicková N; Brdicka T; Andera L; Spicka J; Angelisová P; Milgram SL; Horejsí V
FEBS Lett; 2001 Oct; 507(2):133-6. PubMed ID: 11684085
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of lipid rafts in human activated T cells.
Tani-ichi S; Maruyama K; Kondo N; Nagafuku M; Kabayama K; Inokuchi J; Shimada Y; Ohno-Iwashita Y; Yagita H; Kawano S; Kosugi A
Int Immunol; 2005 Jun; 17(6):749-58. PubMed ID: 15967787
[TBL] [Abstract][Full Text] [Related]
20. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.
Brdicka T; Pavlistová D; Leo A; Bruyns E; Korínek V; Angelisová P; Scherer J; Shevchenko A; Hilgert I; Cerný J; Drbal K; Kuramitsu Y; Kornacker B; Horejsí V; Schraven B
J Exp Med; 2000 May; 191(9):1591-604. PubMed ID: 10790433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
